Cointime

  • News
  • Insight
  • Currencies
  • Columns
  • Events
  • Bitcoin $75,617.85 -0.74%
  • Ethereum $2,307.40 -0.94%
  • BNB $630.13 -0.07%
  • Optimism $0.12 -2.59%
  • Arbitrum $0.13 -3.11%
  • Solana $85.35 -0.75%
  • Polygon $0.22 +2.77%
  • Cosmos $1.81 +0.13%
  • Avalanche $9.34 +0.55%
  • Bitcoin $75,617.85 -0.74%
  • Ethereum $2,307.40 -0.94%
  • BNB $630.13 -0.07%
  • Optimism $0.12 -2.59%
  • Arbitrum $0.13 -3.11%
  • Solana $85.35 -0.75%
  • Polygon $0.22 +2.77%
  • Cosmos $1.81 +0.13%
  • Avalanche $9.34 +0.55%
Home / Karyopharm Therapeutics / investors

Karyopharm Therapeutics

company

Investors

Number of Lead Investors
Number of Investors
5
14
Karyopharm Therapeutics is funded by 14 investors. Avidity Partners and Foresite Capital are the most recent investors.
Investor Name Lead Investor Funding Round
Avidity Partners Yes Post-IPO Equity
Foresite Capital Yes Series B
Chione Yes Series A
Multiple Myeloma Research Foundation Yes Grant
Adage Capital Management - Post-IPO Equity
Armistice Capital - Post-IPO Equity
HealthCor Partners - Post-IPO Equity
Heights Capital Management - Post-IPO Equity
Marshall Wace - Post-IPO Equity
Rubric Capital Management - Post-IPO Equity
SilverArc Capital - Post-IPO Equity
Surveyor Capital - Post-IPO Equity
Delphi Ventures - Series B
New Leaf Venture Partners - Series B

Contact

Newton,Massachusetts,United States
+1 617 658 0600
Cointime
Insight
  • Latest News
  • Web3
  • Blockchain
  • Metaverse
  • Bitcoin
  • Ethereum
  • NFT
  • DeFi
Features
  • Startups
  • Research
  • Technology
  • Topics
  • Columns
  • Currencies
  • Events
  • Tags
RSS
  • Latest News
  • Startups
  • Research
  • Technology
Company
  • About
  • Advertise
  • Disclaimers
  • © 2023 Cointime. All rights reserved.
  • Privacy Policy
  • Terms & Conditions